Pacira BioSciences
PCRX
25.20
+0.44
+1.78%
Pacira BioSciences
US · PCRX
#3244 by market cap
25.20
+0.44
+1.78%
Live - 5344 symbols - heartbeat 223s ago
· 2026-10-08 09:20
Pre-market
36.33
+44.17%
After-hours
25.20
0.00%
Overnight
25.28
+0.32%
- Market cap
- 1.00B
- P/E (TTM)i
- 72.00
- P/Bi
- 1.49
- EPSi
- 0.16
- Div yieldi
- 0.00%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on PCRX?
Anonymous reader poll. Unscientific, not investment advice.
About Pacira BioSciences
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Brisbane, CA.
- Founded
- 2006
- CEO
- Mr. Frank D. Lee
- Employees
- 829
- Headquarters
- Brisbane, California, United States of America
- Fiscal year end
- 12-31
- Website
- pacira.com
Company profile
- Exchange
- US
- Symbol
- PCRX
- Market-cap rank
- #3244
- Market cap
- 1.00B
- Float cap
- 912.08M
- Shares out
- 39.86M
- Float shares
- 36.19M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-10-08 09:20:28 · For reference only, not investment advice and not tailored to your situation.